Risk factors and targeted precaution of gastric retention in patients after esophageal cancer surgery receiving enteral nutritional

Xin Miao; Tang Xinyan

doi:10.16689/j.cnki.cn11-9349/r.2020.04.016

PDF(463 KB)

Electronic Journal of Metabolism and Nutrition of Cancer ›› 2020, Vol. 7 ›› Issue (4) : 460-464. DOI: 10.16689/j.cnki.cn11-9349/r.2020.04.016

Risk factors and targeted precaution of gastric retention in patients after esophageal cancer surgery receiving enteral nutritional

Xin Miao, Tang Xinyan

Author information +

History +

Abstract

To observe the risk factors and targeted precaution of gastric retention in patients after esophageal cancer surgery receiving enteral nutritional. Methods Retrospective analysis of the incidence and time of enteral nutrition in 165 cases after esophageal cancer surgery were performed. The data were compared using single factor and multivariate analysis methods to investigate and analyze the factors that may affect gastric retention. Results The incidence of gastric retention in patients after esophageal cancer operation receiving enteral nutrition was 21.21%. Chi-square test or t-test was used to screen the relevant factors of gastric retention. The results found that the main related factors were hypotension, hypokalemia, constipation, hyperglycemia, infection, electrolyte disturbances （P<0.05）. Furthermore, multivariate analysis using logistic regression analysis found that hyperglycemia, hypokalemia, constipation, and electrolyte disturbance were risk factors of postoperative gastric retention in patients with esophageal cancer after enteral nutrition （P<0.05）. Conclusion The incidence is high of gastric retention after esophageal cancer surgery receiving enteral nutritional. Hyperglycemia, hypokalemia, constipation, and electrolyte disturbances were the risk factors of postoperative gastric retention. It is necessary to take the precaution to reduce the risk.

Key words

Esophageal cancer / Enteral nutrition / Gastric retention / Risk factors / Prevention

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Xin Miao, Tang Xinyan. Risk factors and targeted precaution of gastric retention in patients after esophageal cancer surgery receiving enteral nutritional[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2020, 7(4): 460-464 https://doi.org/10.16689/j.cnki.cn11-9349/r.2020.04.016

References

1.WU J, HUANG C, XIAO H, et al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer［J］. Nutrition, 2013, 29(11-12):1310-1314.
2.Rebecca L S, Kimberly D M, Ahmedin J. Cancer statistics, 2019［J］. CA Cancer J Clin, 2019, 69(1):7-34.
3.毛友生, 高树庚, 王群, 等.中国食管癌临床流行特征及外科治疗概况大数据分析［J］.中华肿瘤杂志, 2020, 42(3):228-233.
4.BOZZETTI F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients［J］. Nutrition, 2002, 18(11-12):953-959.
5.JORDAN T, MASTNAK D M, PALAMAR N. Nutritional therapy for patients with esophageal cancer［J］. Nutr Cancer,2018；70(1):23-29.
6.STEENHAGEN E, VAN VULPEN J K, VAN HILLEGERSBERG R. Nutrition in peri-operative esophageal cancer management［J］.Expert Rev Gastroenterol Hepatol, 2017,11(7): 663- 672.
7.KATO H, FUKUCHI M, MIYAZAKI T, et al. Surgical treatment for esophageal cancer.Current issues［J］. Dig Surg, 2007, 24(2): 88-95.
8.NUMICO G, LONGO V, COURTHOD G, et al. Cancer survivorship: long-term side-effects of anticancer treatments of gastrointestinal cancer［J］.Curr Opin Oncol,2015,27(4):351-357.
9.YING J, ZHANG M, QIU X.The potential of herb medicines in the treatment of esophageal cancer［J］. Biomed Pharmacother,2018,103:381-390.
10.舒晓亮, 赵坚, 于婷婷, 等.国产整蛋白型肠内营养对食管癌手术患者营养状况和胃肠道耐受性的影响［J］.肠外与肠内营养, 2015, 22(1):3-5, 9.
11.姜美霞, 杨昌志, 李佳琪, 等. 食管癌术后肠内营养患者胃潴留的影响因素分析［J］. 护理学杂志, 2017, 32(6):53-54.
12.王赵杰. 规范化流程护理对肿瘤晚期患者癌痛发生的干预效果［J］. 国际护理学杂志, 2019, 38(15):2472-2475.
13.中国早期食管癌及癌前病变筛查专家共识意见(2019年, 新乡)［J］.中华健康管理学杂志, 2019, 13(6):465-473.
14.李晓雷, 徐俊, 梁青松, 等.胸腔镜食管癌根治术的临床效果及术后并发症观察［J］.中国现代手术学杂志, 2017, 21(1):27-30.
15.方萌萌, 赵勇, 王超虹.食管癌患者术后生存质量及护理干预的研究进展［J］.中华现代护理杂志, 2013, 19(25):3157-3159.
16.VILLET S, CHIOLERO R L, BOLLMANN M D, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients［J］. Clin Nutr, 2005, 24(4):502-509.
17.李英, 易红梅, 马瑞东, 等.肺癌术后化疗患者不同营养治疗方式对临床效果的影响［J］.中国现代医学杂志, 2020, 30(17):30-36.
18.狄晓芸.早期肠内营养治疗对重型颅脑损伤患者的临床研究［J］.浙江创伤外科, 2020, 25(4):716-717.
19.ELKE G, SCH D D, ENGEL C, et al. Current practice in nutritional support and its association with mortality in septic patients—Results from a national, prospective, multicenter study［J］. Crit Care Med, 2008, 36(6):1762-1767.
20.金林梅. 神经危重症患者发生胃潴留相关的危险因素及预后分析［D］. 吉林大学, 2013.
21.IKEDA F, KIYOHARA Y. Helicobacter pylori infection and hyperglycemia/diabetes are associated with an increased risk of gastric cancer［J］. Gan To Kagaku Ryoho, 2015, 42(5):529-533.
22.吴泉霞, 赵劢, 谭至柔, 等.糖尿病胃轻瘫大鼠胃窦Cajal间质细胞和缝隙连接蛋白43的变化及胰岛素的干预作用［D］.世界华人消化杂志, 2014, 22(29):4399-4405.
23.姜月秋.胰腺癌合并糖尿病患者术后胃排空延迟的观察与护理体会［J］.糖尿病新世界, 2017, 20(2):112-113.
24.姜美霞. 肺癌术后患者肠内营养致胃潴留的影响因素分析［J］. 护理学杂志, 2013, 28(20):67-68.
25.陈厚兄. 胃大部分切除术后急性胃潴留64例分析［J］. 长江大学学报(自科版)医学卷, 2010, 07(2):34-35.
26.史益凡, 陈启仪, 倪玲, 等.早期肠内营养对混合型顽固性便秘患者金陵术后免疫功能和临床结局的影响［J］.肠外与肠内营养, 2015, 22(6):343-347.
27.ZHANG Y, YANG X, GENG D, et al. The change of health-related quality of life after minimally invasive esophagectomy for esophageal cancer: a meta-analysis［J］. World J Surg Oncol, 2018, 16(1):97-109.
28.邱丽芳, 张曦, 林秀霞. 瓣膜置换术后危重患者肠内营养治疗并发胃潴留的影响因素分析［J］. 福建医药杂志, 2018, 40(4):149-150.
29.徐菁. 术前血清白蛋白水平对结直肠癌患者行根治性切除术后发病率和死亡率的预测价值［J］. 中国普外基础与临床杂志, 2016, 23(12): 1529-1529.
30.WESSELINK E, KOEKKOEK KWAC, LOOIJEN M, et al. Associations of hyperosmolar medications administered via nasogastric or nasoduodenal tubes and feeding adequacy, food intolerance and gastrointestinal complications amongst critically ill patients: a retrospective study［J］. Clin Nutr ESPEN,2018,25:78-86.